Stephan Brachmann

  • Original Articles

    Manifestation pattern of 343 antiresorptive-related osteonecroses of the jaw considering the etiologic factor – consequences for the dental practice

    Introduction: Antiresorptives are used in patients with osteoporosis and malignant tumors to inhibit resorption processes in the bone. Antiresorptive-related osteonecrosis of the jaw (ARONJ) is an adverse drug reaction and is associated with a considerable impairment of quality of life. Therefore,...

    Issue 5/2021

    read